Canadian Retina & Vitreous Society
Retinal Vascular Diseases and Basic Science
Monday, June 22
Harbour A, 0800�0930
Objectives
At the end of this session, participants will be able to:
- integrate new approaches to the management of retinal
vascular diseases into their practice
- assess new advances in basic science research in the area
of retinal disease
- compare new animal models and imaging techniques for
the retina and retinal diseases
Guest
Joan Miller, MD
Moderator
Peter Kertes
| 0800 | Neuroprotection for retinal disease
Joan Miller |
| 0815 | Discussion |
| 0820 | Quantitatively modeling ocular drug flow using
micro-CT acquired images
Corey A. Smith, Timothy A Newson, Kevin Leonard,
David Holdsworth, Chris Norley, Joesph Barfett,
Cindy Hutnik, Kathleen A. Hill |
| 0825 | Improved imaging with the hand-held spectral
domain ocular coherence tomography and
surgical visualization with the intraocular
endoscope in the management of advanced
retinopathy of prematurity
Rajeev H. Muni, Thomas C. Lee |
| 0830 | Discussion |
| 0834 | Structural and functional correlates of diabetic
macular edema using OCT, microperimetry and
multifocal ERG
Stuart G. Coupland, Danah Al-Breiki,
Bernard Hurley, Brian C. Leonard |
| 0839 | Anesthetic and pharmacological agents alter
the optic nerve head component (ONHC) of
the porcine multifocal electroretinogram (mfERG)
Rita Buffa, Aphrodite Dracopoulos, Shelley R. Boyd |
| 0844 | Discussion |
| 0849 | The Renin-Angiotensin System (RAS) induces
Erythropoietin (Epo) expression in the mRen(2)
transgenic rat retina: implications for diabetic
retinopathy
Shelley R. Boyd, Xu Zhao, Hai Wang |
| 0854 | Ocular phenotyping in a memantine-treated
mouse model of retinal degeneration
Thomas C. MacPherson, Kevin C. Leonard,
Cindy M. Hutnik, Kathleen A. Hill |
| 0859 | Discussion |
| 0904 | In vitro bovine lens toxicity model for testing
novel intraocular dyes for chromovitrectomy
Lisa M. Lagrou, John R. Gonder, David McCanna,
Jacob G. Sivak |
| 0909 | Photodynamic therapy with Verteporfin for
chronic central serous chorioretinopathy
Patrick Gooi, Tom Gonder, Amin Kherani,
Geoff Williams |
| 0914 | Oral versus topical diclofenac for pain
prevention during panretinal photocoagulation
Peter A. Zakrzewski, Heather L. O�Donnell,
Wai-Ching Lam |
| 0924 | Discussion |
Age-related Macular Degeneration and Choroidal Neovascularization
Monday, June 22
Harbour A, 1330�1500
Objectives
At the end of this session, participants will be able to:
- integrate new approaches to choroidal neovascularization
into practice
- describe potential side effects and complications related
to anti-VEGF therapies
- compare new imaging modalities for age-related macular
degeneration (AMD)
Guest
Joan Miller, MD
Moderator
Jean-Daniel Arbour
| 1330 | AMD: Genetics update
Joan Miller |
| 1345 | Discussion |
| 1350 | The harlequin carrier mouse (hqX): A new
model for aging-associated retinal degeneration
Alex M. Laliberte, Thomas M. MacPherson,
Anita Prtenjaca, Cindy M. Hutnik, Kathleen A. Hill |
| 1355 | The efficacy of Ranibizumab in the
treatment for exudative age-related macular
degeneration in patients previously treated by
other modalities
Jonathan J. Bastian, Matt Regan, Amber Sheikh,
Ravi Nrusimhadevera, Kevin Colleaux |
| 1400 | Discussion |
| 1404 | Management of pediatric choroidal neovascular
membranes with intravitreal anti-VEGF agents:
A retrospective consecutive case series
Radha P. Kohly, Rajeev H. Muni, Peter J. Kertes,
Wai-Ching Lam |
| 1409 | Management options for massive hemorrhagic
retinal detachment in macular degeneration
Thomas M. Johnson |
| 1414 | Discussion |
| 1420 | Comparison of OCT vs. Fluorescein angiography
for detection of disease activity in treated
exudative AMD
Chirag R. Shah, Michael Brent, Wai-Ching Lam,
Robert Devenyi, Mark Mandelcorn |
| 1425 | Does autofluorescence changes in subfoveal
neovascular-AMD have significant correlation
with central macular thickness after intravitreal
injection of Bevacizumab?
Mohammad Riazi-Esfahani, Hamid Ahmadieh,
Mohsen Norouzifard, Niloofar Piri, Alireza Salehi |
| 1430 | Discussion |
| 1434 | Incidence of ocular complications following
intravitreal bevacizumab (Avastin�) injections
Riley Hall, Nidhi Lodha, Patrick Mitchell,
Geoff Williams, Amin Kherani |
| 1439 | Acute intraocular inflammation following
intravitreal injection of bevacizumab - a cluster
of cases
Michael P. Fielden, Brian Nelson, R. Geoff Williams,
Anna L. Ells, Jag Anand, Amin Kherani |
| 1444 | Outbreak of acute intraocular inflammation
after bevacizumab intravitreal injection: An
epidemiological investigation
Simon Holland, Patrick Ma, David Maberley,
Andrew Merkur, David Albiani, Alan Maberley,
William Ross |
| 1449 | Discussion |
Ocular Tumours and Surgical Retina
Monday, June 22
Harbour A, 1530�1700
Objectives
At the end of this session, participants will be able to:
- describe issues affecting uveal tumor growth
- apply new knowledge regarding posterior vitreous
detachment to practice
- gain new insight into surgery for macular holes
Guest
Joan Miller, MD
Moderators
Hugh McGowan, Kevin Colleaux
| 1530 | Cellular mechanism of proliferative
vitreoretinopathy
Joan Miller |
| 1545 | Discussion |
| 1550 | Chromosomal 6 aberrations in uveal melanoma
and an inflammatory phenotype
Parambir S. Keila, W. Maat, E. S. Jordanova,
W. Kroes, Gre P.M. Luyten, Martine J. Jager |
| 1555 | Choroidal nevi: Growth assessment and
14 years� follow-up with ultrasound
Silvin Bakalian, Susan K. Lindley, Jonathan W. Bush,
Dina Abdulmannan, Miguel N. Burnier |
| 1600 | Discussion |
| 1604 | Growth rate of medium-sized uveal melanoma
before plaque radiotherapy as a prognostic
factor for post-treatment outcome
Hatem Krema, Christine Law, Rand Simpson,
David Payne, Charles Pavlin, Wei Xu |
| 1609 | Uveal melanomas in young patients
Emiliano Fulda, Bruno Fernandes, Hatem Krema,
Rand Simpson |
| 1614 | Management of iris melanomas with
125 iodine plaque radiotherapy
Bruno F. Fernandes, Hatem Krema, Emiliano Fulda,
Charles V. Pavlin, David G. Payne, E. R. Simpson |
| 1619 | Discussion |
| 1625 | Anatomic and functional outcomes in patients
with repeat surgery for idiopathic full thickness
macular holes
Varun Chaudhary, Mark D�Souza, Peter J. Kertes,
Robert G. Devenyi, Wai-Ching Lam |
| 1630 | Morphological features of phakic and
pseudophakic retinal detachments
Mark A. Mandell, Rajeev H. Muni, Steve M. Conti,
Feisal A. Adatia, Mir R. Nabavi, Wai-Ching Lam,
Robert Devenyi, Peter J. Kertes |
| 1635 | Discussion |
| 1639 | Signs and symptoms predictive of retinal tear
in the setting of posterior vitreous detachment:
A meta-analysis
Hussein Hollands, Davin Johnson, David Almeida,
Sanjay Sharma |
| 1644 | Nevanac in the management of chronic
macular edema
Arif Samad, Alison Che |
| 1649 | Macular hole in Behcet�s Disease: Clinical
features, and outcome of management
Marwan A. Abouammoh, Hassan Al-Dhibi,
Manal M. Bouhaimed, Essam Al-Harthi,
Imtiaz Chaudhry |
| 1654 | Discussion |
|
